title: [Acute lymphoblastic leukemia in children].
abstract: We report our experience over the last seventeen years (1985-2002) of the treatment of acute lymphoblastic leukemia (ALL) in children at the University of Liege Pediatric Department of Hematogy-Oncology (CHU-Sart Tilman and CHR-Citadelle). Seventy seven children are enrolled in our study; the mean follow-up is 6.7 years. The 5 years over all survival and the disease free survival for the entire group are respectively 83% and 79%. Prognostic factors shown in our study are sex, high white blood cells counts at diagnosis and immunophenotypes.
authors.affiliation: CHR Citadelle, Liège.
authors.forename: S
authors.initials: S
authors.lastname: Panizzoto
authors.forename: M F
authors.initials: MF
authors.lastname: Dresse
authors.forename: V
authors.initials: V
authors.lastname: Schmitz
authors.forename: P
authors.initials: P
authors.lastname: Forget
authors.forename: X
authors.initials: X
authors.lastname: Kurz
authors.forename: Cl
authors.initials: C
authors.lastname: Hoyoux
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012189:Retrospective Studies; D017211:Treatment Failure